Literature DB >> 28674911

The Basic Metabolic Profile in Heart Failure-Marker and Modifier.

Ahmed Elfar1, Kamalanathan K Sambandam2.   

Abstract

PURPOSE OF REVIEW: The physiologic determinants of each of the components of the basic metabolic profile in patients with heart failure will be explored. Additionally, the review will discuss the prognostic value of alterations in the basic metabolic profile as well as their effects on management. RECENT
FINDINGS: Abnormalities in the basic metabolic profile have significant correlation with clinical outcomes and can modify treatment in heart failure. Hypochloremia has recently received increased attention for these reasons. Elevated creatinine, increased blood urea nitrogen, hyponatremia, and hypochloremia correlate with worse mortality and diuretic resistance in heart failure. Hypokalemia, even when mild, has proven to be a worse clinical indicator than modest elevations in serum potassium. Hypochloremia is mechanistically linked to hyponatremia and metabolic alkalosis, but recent compelling data suggests that it can provide more discriminating prognostic information. Knowledge of the physiologic basis for each of these alterations informs their management.

Entities:  

Keywords:  Heart failure; Hypochloremia; Hypokalemia; Hyponatremia; Metabolic alkalosis; Renal insufficiency

Mesh:

Substances:

Year:  2017        PMID: 28674911     DOI: 10.1007/s11897-017-0344-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  40 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

2.  Importance of Abnormal Chloride Homeostasis in Stable Chronic Heart Failure.

Authors:  Justin L Grodin; Frederik H Verbrugge; Stephen G Ellis; Wilfried Mullens; Jeffrey M Testani; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

Review 3.  Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.

Authors:  Sumeet Gandhi; Wassim Mosleh; Robert B H Myers
Journal:  Int J Cardiol       Date:  2014-03-14       Impact factor: 4.164

4.  Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF).

Authors:  Justin L Grodin; Jie-Lena Sun; Kevin J Anstrom; Horng H Chen; Randall C Starling; Jeffrey M Testani; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2016-09-30       Impact factor: 2.778

5.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Wendy Gattis Stough; Barry H Greenberg; Christopher M O'Connor; Lilin She; Clyde W Yancy; James Young; Gregg C Fonarow
Journal:  Eur Heart J       Date:  2007-02-19       Impact factor: 29.983

6.  Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.

Authors:  Orly Vardeny; Brian Claggett; Inder Anand; Patrick Rossignol; Akshay S Desai; Faiez Zannad; Bertram Pitt; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-05-08       Impact factor: 8.790

Review 7.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis.

Authors:  Kevin Damman; Mattia A E Valente; Adriaan A Voors; Christopher M O'Connor; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur Heart J       Date:  2013-10-27       Impact factor: 29.983

8.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

9.  Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  Stephen J Greene; Mihai Gheorghiade; Muthiah Vaduganathan; Andrew P Ambrosy; Robert J Mentz; Haris Subacius; Aldo P Maggioni; Savina Nodari; Marvin A Konstam; Javed Butler; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2013-07-11       Impact factor: 15.534

10.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

Authors:  Douglas S Lee; Peter C Austin; Jean L Rouleau; Peter P Liu; David Naimark; Jack V Tu
Journal:  JAMA       Date:  2003-11-19       Impact factor: 56.272

View more
  1 in total

Review 1.  Prognostic Significance of Hyponatremia in ST-elevation Myocardial Infarction/Heart Failure Patients.

Authors:  Vraj Shah; Nusrat Jahan
Journal:  Cureus       Date:  2019-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.